Key Points
- Glenbrook Capital Management bought 5,399 Senestech shares on Jan 30 at $1.87 (≈$10,096) and then 42,739 shares on Feb 2 at $1.98 (≈$84,623), bringing its holding to 551,046 shares — a roughly 0.99% increase valued at about $1.03 million.
- Senestech is a tiny microcap (~$9.8M) with negative earnings
Senestech, Inc. (NASDAQ:SNES - Get Free Report) major shareholder Glenbrook Capital Management bought 5,399 shares of the company's stock in a transaction on Friday, January 30th. The stock was bought at an average cost of $1.87 per share, with a total value of $10,096.13. Following the completion of the purchase, the insider owned 551,046 shares of the company's stock, valued at approximately $1,030,456.02. The trade was a 0.99% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Major shareholders that own more than 10% of a company's stock are required to disclose their transactions with the SEC.
Glenbrook Capital Management also recently made the following trade(s):
- On Monday, February 2nd, Glenbrook Capital Management purchased 42,739 shares of Senestech stock. The shares were bought at an average cost of $1.98 per share, for a total transaction of $84,623.22.
Senestech Stock Performance
Shares of Senestech stock opened at $1.88 on Wednesday. The company has a debt-to-equity ratio of 0.01, a current ratio of 15.75 and a quick ratio of 14.73. The firm has a 50 day simple moving average of $2.33 and a 200 day simple moving average of $3.59. Senestech, Inc. has a fifty-two week low of $1.30 and a fifty-two week high of $6.24. The firm has a market cap of $9.81 million, a P/E ratio of -0.52 and a beta of 0.21.
Senestech (NASDAQ:SNES - Get Free Report) last posted its quarterly earnings data on Monday, November 10th. The company reported ($0.28) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.35) by $0.07. The firm had revenue of $0.69 million for the quarter, compared to the consensus estimate of $0.73 million. Senestech had a negative return on equity of 98.35% and a negative net margin of 253.54%. Sell-side analysts predict that Senestech, Inc. will post -10.22 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Senestech
Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Geode Capital Management LLC acquired a new position in Senestech in the second quarter valued at about $59,000. Corsair Capital Management L.P. acquired a new position in shares of Senestech during the 2nd quarter worth about $255,000. Jane Street Group LLC bought a new stake in shares of Senestech in the 2nd quarter valued at about $161,000. Essex Investment Management Co. LLC bought a new stake in shares of Senestech in the 3rd quarter valued at about $115,000. Finally, Sabby Management LLC acquired a new stake in shares of Senestech in the 3rd quarter valued at approximately $313,000. Institutional investors own 5.19% of the company's stock.
Analysts Set New Price Targets
Separately, Weiss Ratings reiterated a "sell (e+)" rating on shares of Senestech in a research report on Monday, December 29th. One investment analyst has rated the stock with a Strong Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Hold".
View Our Latest Stock Report on SNES
About Senestech
(
Get Free Report)
SenesTech, Inc (NASDAQ: SNES) is a biotechnology company specializing in non-lethal pest management solutions. The company's core focus is the development and commercialization of fertility-based control methods for commensal rodents, providing an alternative to traditional rodenticides. By targeting the reproductive cycle of rats, SenesTech aims to reduce rodent populations over time without the use of toxic chemicals, offering a more sustainable approach for pest management professionals.
The company's flagship product, ContraPest®, is an EPA-registered liquid bait that disrupts rodent reproduction.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
